The hemodialysis and peritoneal dialysis market in Europe is expected to grow from US$ 25,140.48 million in 2022 to US$ 36,242.91 million by 2028; it is estimated to grow at a CAGR of 6.3% from 2022 to 2028.
The rising prevalence of diabetes is the major factor driving the Europe hemodialysis and peritoneal dialysis market. Diabetes occurs when blood glucose, also called blood sugar, is too high. High blood glucose can cause health problems over time. The main types of diabetes are type 1, type 2, and gestational. With diabetes, the small blood vessels in the body are injured. When the blood vessels in the kidneys are injured, the kidneys cannot clean the blood properly. The body will retain more water and salt than it should, resulting in weight gain and ankle swelling. Also, waste materials will build up in the blood. Diabetes may also cause damage to nerves in the body, which can cause difficulty emptying the bladder. The pressure resulting from a full bladder can back up and injure the kidneys. According to a study, about 30% of patients with Type 1 (juvenile-onset) diabetes and 10–40% of those with Type 2 (adult-onset) diabetes will eventually suffer from kidney failure. Therefore, an increase in the prevalence of diabetes also increases the chances of dialysis for a patient's survival, thereby fueling the market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe hemodialysis and peritoneal dialysis market. The Europe hemodialysis and peritoneal dialysis market is expected to grow at a good CAGR during the forecast period.
Europe Hemodialysis and Peritoneal Dialysis Market Segmentation
The Europe hemodialysis and peritoneal dialysis market is segmented into type, product, end user, and country. Based on type, the market is bifurcated into hemodialysis and peritoneal dialysis. In 2022, the hemodialysis segment is expected to hold a larger market share. Based on product, the hemodialysis and peritoneal dialysis market is segmented into devices, consumables, and services. The services segment is likely to hold the largest market share in 2022. Based on end user, the market is segmented into hospital-based and home-based. The hospital-based segment is expected to account for a larger share in 2022. Based on country, the Europe hemodialysis and peritoneal dialysis market is segmented into France, Germany, Italy, Spain, the UK, and the Rest of Europe. Germany is anticipated to hold the largest market share in 2022.
Asahi Kasei Medical Co., Ltd.; B. Braun Melsungen AG; Baxter International Inc.; DaVita Inc.; Dialife SA; Diaverum; Fresenius Medical Care AG & Co KGaA; and Nipro Medical Corporation are among the leading companies operating in the Europe hemodialysis and peritoneal dialysis market.